Breast cancer in young women in a limited-resource environment

World Journal of Surgery

Volumn 34, Issue 7, 2010, Pages 1427-1433

  Basro, Sarinah ^a   Apffelstaedt, Justus P ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; MASTECTOMY; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; SEGMENTAL MASTECTOMY; SOUTH AFRICA; STATISTICS; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY; MASTECTOMY, SEGMENTAL; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955467558     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0299-5     Document Type: Article

References (58)

1. M Colleoni N Rotmensz C Robertson, et al. 2002 Very young women (<35 years) with operable breast cancer: features of disease at presentation Ann Oncol 13 2 273 279 10.1093/annonc/mdf039 1:STN:280:DC%2BD387ltl2gtw%3D%3D 11886005
2. N Kroman MB Jensen J Wohlfahrt, et al. 2000 Factors influencing the effect of age on prognosis in breast cancer: population based study BMJ 320 7233 474 478 10.1136/bmj.320.7233.474 1:STN:280:DC%2BD3c7ktlKitw%3D%3D 10678859
3. A Kwong P Cheung S Chan, et al. 2008 Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg 32 12 2554 2561 10.1007/s00268-008-9589-6 18408960
4. M Chung HR Chang KI Bland, et al. 1996 Younger women with breast carcinoma have a poorer prognosis than older women Cancer 77 1 97 103 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3 1:STN:280:DyaK283itlegtQ%3D%3D 8630946 (Pubitemid 26002742)
5. E Yildirim T Dalgic U Berberoglu 2000 Prognostic significance of young age in breast cancer J Surg Oncol 74 4 267 272 10.1002/1096-9098(200008)74: 4<267::AID-JSO5>3.0.CO;2-N 1:STN:280:DC%2BD3cvlvFGmsg%3D%3D 10962458 (Pubitemid 30660816)
6. AM Gonzalez-Angulo K Broglio SW Kau, et al. 2005 Women age < or = 35 years with primary breast carcinoma: disease features at presentation Cancer 103 12 2466 2472 10.1002/cncr.21070 15852360 (Pubitemid 40800523)
7. MC Hartley BP McKinley EA Rogers, et al. 2006 Differential expression of prognostic factors and effect on survival in young (< or = 40) breast cancer patients: a case-control study Am Surg 72 12 1189 1194 17216817
8. DP Winchester RT Osteen HR Menck 1996 The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age Cancer 78 8 1838 1843 10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3. 0.CO;2-Y 1:STN:280:DyaK2s%2Fht1ertw%3D%3D 8859200 (Pubitemid 26330915)
9. AL Feldman JP Welch 1998 Long-term outcome in women less than 30 years of age with breast cancer J Surg Oncol 68 3 193 198 10.1002/(SICI)1096- 9098(199807)68:3<193::AID-JSO12>3.0.CO;2-2 1:STN:280:DyaK1czmsV2ntg%3D%3D 9701214 (Pubitemid 28359620)
10. PC Dubsky MF Gnant S Taucher, et al. 2002 Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer Clin Breast Cancer 3 1 65 72 10.3816/CBC.2002.n.013 12020397
11. Q Xiong V Valero V Kau, et al. 2001 Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience Cancer 92 10 2523 2528 10.1002/1097-0142(20011115)92:10<2523:: AID-CNCR1603>3.0.CO;2-6 1:STN:280:DC%2BD3Mnps1arsQ%3D%3D 11745185 (Pubitemid 33049434)
12. C Gajdos PI Tartter IJ Bleiweiss, et al. 2000 Stage 0 to stage III breast cancer in young women J Am Coll Surg 190 5 523 529 10.1016/S1072-7515(00)00257- X 1:STN:280:DC%2BD3c3lvV2mtA%3D%3D 10801018 (Pubitemid 30230698)
13. AJ Nixon D Neuberg DF Hayes, et al. 1994 Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer J Clin Oncol 12 5 888 894 1:STN:280:DyaK2c3hs12gtA%3D%3D 8164038 (Pubitemid 24145313)
14. J Peto N Collins R Barfoot, et al. 1999 Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 91 11 943 949 10.1093/jnci/91.11.943 1:CAS:528:DyaK1MXjvFOmtb4%3D 10359546
15. MG FitzGerald DJ MacDonald M Krainer, et al. 1996 Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer N Engl J Med 334 3 143 149 10.1056/NEJM199601183340302 1:CAS:528:DyaK28Xos1GlsA%3D%3D 8531968 (Pubitemid 26017951)
16. AA Langston KE Malone JD Thompson, et al. 1996 BRCA1 mutations in a population-based sample of young women with breast cancer N Engl J Med 334 3 137 142 10.1056/NEJM199601183340301 1:CAS:528:DyaK28Xos1Glsw%3D%3D 8531967 (Pubitemid 26017950)
17. D Turchetti L Cortesi M Federico, et al. 2000 BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer Eur J Cancer 36 16 2083 2089 10.1016/S0959-8049(00)00287-2 1:CAS:528:DC%2BD3cXosFKhtLs%3D 11044645
18. JH Sng J Chang F Feroze, et al. 2000 The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives Br J Cancer 82 3 538 542 10.1054/bjoc.1999.0960 1:CAS:528:DC%2BD3cXht1eis7g%3D 10682662
19. JT Bergthorsson B Ejlertsen JH Olsen, et al. 2001 BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age J Med Genet 38 6 361 368 10.1136/jmg.38.6.361 1:CAS:528:DC%2BD3MXltFeru78%3D 11389159
20. RW Carlson BO Anderson R Chopra, et al. 2003 Treatment of breast cancer in countries with limited resources Breast J 9 Suppl 2 S67 S74 10.1046/j.1524-4741.9.s2.6.x 12713499 (Pubitemid 36627149)
21. A Eniu RW Carlson Z Aziz, et al. 2006 Breast cancer in limited-resource countries: treatment and allocation of resources Breast J 12 Suppl 1 S38 S53 10.1111/j.1075-122X.2006.00202.x 16430398 (Pubitemid 43385272)
22. SE Singletary C Allred P Ashley, et al. 2002 Revision of the American Joint Committee on Cancer staging system for breast cancer J Clin Oncol 20 17 3628 3636 10.1200/JCO.2002.02.026 12202663 (Pubitemid 34983222)
23. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 5 403 410 10.1111/j.1365-2559. 1991.tb00229.x 1:STN:280:DyaK38%2FpvVSltw%3D%3D 1757079
24. Agenbag GM, Warnich L, Scholtz CL et al (2005) BRCA1 and BRCA2 mutation screening facilitates an improved diagnostic service for breast cancer in South Africa. Thesis
25. MD Reeves TM Yawitch NC van der Merwe, et al. 2004 BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families Int J Cancer 110 5 677 682 10.1002/ijc.20186 1:CAS:528:DC%2BD2cXkvFOksL0%3D 15146556 (Pubitemid 38746025)
26. Bland M (1995) Life-table analysis and Kaplan-Meier graph. An introduction to medical statistics, 2nd edn. Oxford University Press, New York, pp 279-286
27. H Amir G Kwesigabo MR Aziz, et al. 1996 Breast cancer and conservative surgery in sub-Saharan Africa East Afr Med J 73 2 83 87 1:STN:280: DyaK28zkvFKnsg%3D%3D 8756044
28. AR Adesunkanmi OO Lawal KA Adelusola, et al. 2006 The severity, outcome and challenges of breast cancer in Nigeria Breast 15 3 399 409 10.1016/j.breast.2005.06.008 1:STN:280:DC%2BD28zltFaqtQ%3D%3D 16085418 (Pubitemid 43812214)
29. AR Walker FI Adam BF Walker 2004 Breast cancer in black African women: a changing situation J R Soc Health 124 2 81 85 10.1177/146642400412400212 (Pubitemid 38444028)
30. M Hoffman H de Pinho D Cooper, et al. 2000 Breast cancer incidence and determinants of cancer stage in the Western Cape S Afr Med J 90 12 1212 1216 1:STN:280:DC%2BD3M7otlantQ%3D%3D 11234652
31. G Agarwal PV Pradeep V Aggarwal, et al. 2007 Spectrum of breast cancer in Asian women World J Surg 31 5 1031 1040 10.1007/s00268-005-0585-9 17387549 (Pubitemid 46716756)
32. CA Adebamowo OO Adekunle 1999 Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria Br J Surg 86 5 665 668 10.1046/j.1365-2168.1999.01117.x 1:STN:280:DyaK1M3ptV2itQ%3D%3D 10361191 (Pubitemid 29248362)
33. DA Vorobiof F Sitas G Vorobiof 2001 Breast cancer incidence in South Africa J Clin Oncol 19 18 Suppl 125S 127S 1:STN:280:DC%2BD3MrisFCrsA%3D%3D 11560987
34. S Aebi S Gelber M Castiglione-Gertsch, et al. 2000 Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355 9218 1869 1874 10.1016/S0140-6736(00)02292-3 1:CAS:528:DC%2BD3cXkt1Crsbs%3D 10866443
35. M Colleoni N Rotmensz G Peruzzotti, et al. 2006 Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease Ann Oncol 17 10 1497 1503 10.1093/annonc/mdl145 1:STN:280:DC%2BD28rnsFyltQ%3D%3D 16798834 (Pubitemid 44542034)
36. S Aebi 2005 Special issues related to the adjuvant therapy in very young women Breast 14 6 594 599 10.1016/j.breast.2005.08.011 16185868 (Pubitemid 41683585)
37. Early Breast Cancer Trialists' Collaborative Group 1996 Ovarian ablation in early breast cancer: overview of the randomised trials Lancet 348 1189 1196 10.1016/S0140-6736(96)05023-4 (Pubitemid 26361605)
38. AC Voogd M Nielsen JL Peterse, et al. 2001 Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials J Clin Oncol 19 6 1688 1697 1:STN:280:DC%2BD3M3gsl2nsg%3D%3D 11250998
39. JM Kurtz J Jacquemier R Amalric, et al. 1990 Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8 4 591 598 1:STN:280:DyaK3c7ovVCmug%3D%3D 2313329
40. R Arriagada MG Le G Contesso, et al. 2002 Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer Ann Oncol 13 9 1404 1413 10.1093/annonc/mdf227 1:STN:280:DC%2BD38vjvVGjuw%3D%3D 12196366
41. JM Kurtz JM Spitalier R Amalric, et al. 1988 Mammary recurrences in women younger than forty Int J Radiat Oncol Biol Phys 15 2 271 276 1:STN:280:DyaL1c3pvVeiuw%3D%3D 3403310
42. Z Aziz J Iqbal M Akram 2008 Effect of social class disparities on disease stage, quality of treatment and survival outcomes in breast cancer patients from developing countries Breast J 14 4 372 375 10.1111/j.1524-4741.2008.00601.x 18540953
43. JT Anim 1993 Breast cancer in sub-Saharan African women Afr J Med Med Sci 22 1 5 10 1:STN:280:DyaK2M7ktFymsA%3D%3D 7839882
44. EM Murray 2003 Medical and radiation oncology for breast cancer in developing countries with particular reference to locally advanced breast cancer World J Surg 27 8 924 927 10.1007/s00268-003-6977-9 12784147 (Pubitemid 37051944)
45. K Sandelin JP Apffelstaedt H Abdullah, et al. 2002 Breast Surgery International-breast cancer in developing countries Scand J Surg 91 3 222 226 1:STN:280:DC%2BD38nosFGlsQ%3D%3D 12449462
46. HD Bear S Anderson A Brown, et al. 2003 The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 21 22 4165 4174 10.1200/JCO.2003.12. 005 1:CAS:528:DC%2BD2cXpsVajtrg%3D 14559892 (Pubitemid 46606185)
47. IC Smith SD Heys AW Hutcheon, et al. 2002 Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel J Clin Oncol 20 6 1456 1466 10.1200/JCO.20.6.1456 1:CAS:528:DC%2BD38XivFeisbg%3D 11896092 (Pubitemid 34260523)
48. TR Evans A Yellowlees E Foster, et al. 2005 Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an Anglo-Celtic cooperative oncology group study J Clin Oncol 23 13 2988 2995 10.1200/JCO.2005.06.156 1:CAS:528:DC%2BD2MXkslGhu70%3D 15860854 (Pubitemid 46224118)
49. AU Buzdar NK Ibrahim D Francis, et al. 2005 Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer J Clin Oncol 23 16 3676 3685 10.1200/JCO.2005.07.032 1:CAS:528:DC%2BD2MXlslWntr8%3D 15738535
50. SK Mohsin HL Weiss MC Gutierrez, et al. 2005 Neoadjuvant trastuzumab induces apoptosis in primary breast cancers J Clin Oncol 23 11 2460 2468 10.1200/JCO.2005.00.661 1:CAS:528:DC%2BD2MXjvVyktL4%3D 15710948 (Pubitemid 47050836)
51. KE Malone JR Daling JD Thompson, et al. 1998 BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history JAMA 279 12 922 929 10.1001/jama.279.12.922 1:CAS:528:DyaK1cXitlyju7c%3D 9544766 (Pubitemid 28136081)
52. KE Malone JR Daling C Neal, et al. 2000 Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases Cancer 88 6 1393 1402 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0. CO;2-P 1:CAS:528:DC%2BD3cXisVentr0%3D 10717622 (Pubitemid 30155177)
53. N Uhrhammer A Abdelouahab L Lafarge, et al. 2008 BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases Int J Med Sci 5 4 197 202 1:CAS:528:DC%2BD1cXht1amu7rM 18645608
54. Q Gao CA Adebamowo J Fackenthal, et al. 2000 Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer Hum Genet 107 2 192 194 10.1007/s004390000342 1:CAS:528:DC%2BD3cXnsFCjsLk%3D 11030418
55. KD Awadelkarim G Aceto S Veschi, et al. 2007 BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors Breast Cancer Res Treat 102 2 189 199 10.1007/s10549-006-9303-z 1:CAS:528:DC%2BD2sXjt1Kqurc%3D 17333343 (Pubitemid 46452165)
56. BO Anderson CH Yip SD Ramsey, et al. 2006 Breast cancer in limited-resource countries: health care systems and public policy Breast J 12 Suppl 1 S54 S69 10.1111/j.1075-122X.2006.00203.x 16430399 (Pubitemid 43385273)
57. RA Smith M Caleffi US Albert, et al. 2006 Breast cancer in limited-resource countries: early detection and access to care Breast J 12 Suppl 1 S16 S26 10.1111/j.1075-122X.2006.00200.x 16430395 (Pubitemid 43385271)
58. US Albert KD Schulz 2003 Clinical breast examination: what can be recommended for its use to detect breast cancer in countries with limited resources? Breast J 9 Suppl 2 S90 S93 10.1046/j.1524-4741.9.s2.10.x 12713503 (Pubitemid 36627153)